TheraRadar
← Back
Data updated: Mar 29, 2026

IPCA LABS LTD

CardiovascularNeurologyImmunology
Generics

IPCA LABS LTD is a generic drug manufacturer focused on Cardiovascular, Neurology, Immunology.

2006
Since
28
Drugs
-
Trials
616
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

BUPROPION HYDROCHLORIDE 2026-02-25
Labeling
GABAPENTIN 2026-02-24
Labeling
GABAPENTIN 2026-02-18
Labeling
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 2026-02-17
Labeling
GABAPENTIN 2026-02-17
Labeling
GABAPENTIN 2026-02-17
Labeling
TRAMADOL HYDROCHLORIDE 2026-02-13
Labeling
TRAMADOL HYDROCHLORIDE 2026-02-13
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 56%
5 drugs
Neurology 22%
2 drugs
Immunology 11%
1 drugs
Gastroenterology 11%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Bristol-Myers Squibb big-pharma
Immunology, Gastroenterology, Neurology
BAUSCH specialty
Immunology, Cardiovascular, Gastroenterology
Takeda big-pharma
Immunology, Gastroenterology, Neurology
Pfizer big-pharma
Immunology, Gastroenterology
PAI HOLDINGS PHARM big-pharma
Neurology, Cardiovascular, Immunology